| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.054 | 0.3 |